BCM
LVAC

Beryl Capital Management’s LAVA Medtech Acquisition Corp. Class A Common Stock LVAC Stock Holding History

Beryl Capital Management’s Portfolio LVAC Stock Details LVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-998,998
Closed -$9.94M – 204
2022
Q1 		$9.94M Hold
998,998
– – 0.6% 44
2021
Q4 		$9.89M Buy
+998,998
New +$9.89M 0.51% 49

Other funds holding LVAC

SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
GL
Governors Lane New York $1.56B AUM 30.42% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
PMAM
Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 50.48% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

Beryl Capital Management's LVAC Position: Q2 2022 in Review

Beryl Capital Management sold out of LAVA Medtech Acquisition Corp. Class A Common Stock (LVAC) in Q2 2022, closing a stake of 998,998 shares — an estimated $9.94M sold.

Beryl Capital Management first reported a position in LVAC in Q4 2021 and held it in 2 quarters. The position peaked at $9.94M in Q1 2022. 47 funds tracked by Wall St. Rank hold LVAC as of Q2 2022.

  • Beryl Capital Management reported no remaining LAVA Medtech Acquisition Corp. Class A Common Stock position as of Q2 2022 after selling out during the quarter.
  • Beryl Capital Management sold 998,998 LAVA Medtech Acquisition Corp. Class A Common Stock shares in Q2 2022, an estimated $9.94M.
  • Beryl Capital Management first reported a position in LAVA Medtech Acquisition Corp. Class A Common Stock in Q4 2021 and held it in 2 quarters.
  • Beryl Capital Management's LAVA Medtech Acquisition Corp. Class A Common Stock position peaked at $9.94M in Q1 2022.
  • 47 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Class A Common Stock as of Q2 2022.

Based on Beryl Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.